Incidence and Prevalence of Ocular Inflammatory Conditions

members, healthcare plans, ophthalmic clinics, and workplace productivity due to health-related absenteeism. The cost of prescription medicines for ocular allergy was estimated at over $200 million in the US in 2002, with a projected rise of 25% per year as prescription medicines continue to improve and show benefit over less efficacious over-the-counter products. Ocular inflammatory conditions such as seasonal allergic conjunctivitis (SAC), atopic keratoconjunctivitis (AKC), uveitis, dry eye, and routine post-operative inflammation are often treated with corticosteroids. For decades, topical corticosteroids have been used successfully to reduce the signs and symptoms of intraocular and ocular surface inflammation, providing maximal drug delivery to the local target site.